DBV TECHNOLOGIES (EPA:DBV)

PRESS RELEASE

published on 06/23/2026 at 22:30, 2 months 19 days ago

DBV Technologies Announces Inclusion in the Euronext Tech Leaders Index
DBV Technologies has been included in the Euronext Tech Leaders index, spotlighting high-growth European companies in technology and adjacent sectors. The recognition reflects the company's progress in developing innovative treatment options

Technology DBV Technologies Euronext Tech Leaders Index Innovative Treatment Options High-growth European Companies
BRIEF

published on 06/09/2026 at 13:05, 3 months 4 days ago

DBV Technologies cancels a presentation at a Goldman Sachs conference

Goldman Sachs DBV Technologies Daniel Tassé Health Conference VIASKIN® Patch
BRIEF

published on 06/09/2026 at 13:05, 3 months 4 days ago

DBV Technologies Adjusts Attendance at Global Conference

DBV Technologies Food Allergies Epicutaneous Immunotherapy VIASKIN Patch Goldman Sachs Conference
PRESS RELEASE

published on 06/09/2026 at 13:00, 3 months 4 days ago

DBV Technologies Revises Participation in the Goldman Sachs 47th Annual Global Healthcare Conference
DBV Technologies to participate in 1-on-1 investor meetings at Goldman Sachs Annual Global Healthcare Conference. CEO unavailable for fireside chat. Company focused on developing food allergy treatments with VIASKIN patch technology

Investor Meetings DBV Technologies Food Allergies Goldman Sachs Conference VIASKIN Patch Technology
BRIEF

published on 06/08/2026 at 22:40, 3 months 4 days ago

DBV Technologies Unveils Promising Data on Peanut Allergy Treatments

DBV Technologies Viaskin Peanut Patch Peanut Allergy Treatment VITESSE Study THRIVE Study
BRIEF

published on 06/08/2026 at 22:40, 3 months 4 days ago

DBV Technologies: New advances in the treatment of peanut allergy

Immunotherapy DBV Technologies Viaskin Peanut Peanut Allergy SPEED Study
PRESS RELEASE

published on 06/08/2026 at 22:35, 3 months 4 days ago

DBV Technologies to Present New Positive Data from VITESSE Study and Preview Recently Initiated THRIVE Study at the EAACI Congress 2026
DBV Technologies to present new positive data from VITESSE study and preview THRIVE study at EAACI Congress 2026. VIASKIN Peanut Patch efficacy in peanut-allergic children with atopic comorbidities

DBV Technologies Viaskin Peanut Patch VITESSE Study THRIVE Study EAACI Congress 2026
BRIEF

published on 06/08/2026 at 09:37, 3 months 5 days ago

DBV Technologies: JP Morgan Chase & Co. falls below the 10% threshold

Share Capital Voting Rights Threshold Crossing DBV Technologies JP Morgan Chase
BRIEF

published on 06/05/2026 at 22:35, 3 months 7 days ago

DBV Technologies presents at the Goldman Sachs Global Healthcare Conference

Immunotherapy DBV Technologies Viaskin Food Allergies Goldman Sachs Conference
BRIEF

published on 06/05/2026 at 22:35, 3 months 7 days ago

DBV Technologies to Present at Goldman Sachs Healthcare Conference

DBV Technologies Food Allergies Epicutaneous Immunotherapy VIASKIN Patch Goldman Sachs Healthcare Conference

Published on 09/12/2026 at 02:35, 1 day 16 hours ago

Gamma Resources Announces Extension of Private Placement Closing Date
Published on 09/11/2026 at 23:00, 1 day 19 hours ago

Rio Grande Resources Engages Machai Capital for Investor Outreach
Published on 09/11/2026 at 22:05, 1 day 20 hours ago

Usha Resources Announces Leadership Transition
Published on 09/11/2026 at 21:25, 1 day 21 hours ago

Algo Grande Copper Intersects 30.23 Metres Grading 1.5% CuEq, including 3.55 Metres at 9.4% CuEq and 1.2-Metre Interval at 15.8% CuEq, 100 Metres Vertical Step-Out from Historical Intersects
Published on 09/11/2026 at 17:00, 2 days 1 hour ago

Critical Elements Selected for Canada Investment Summit Prospectus, Showcasing Project to Leading Global Investors

View all ACCESSWIRE

Published on 09/12/2026 at 17:50, 1 day ago

New Delhi Marks UN Day for South-South Cooperation with Push to Scale Dryland Innovation Across the Global South
Published on 09/12/2026 at 07:30, 1 day 11 hours ago

NAGRAVISION Secures Formula 1 Content for RTL Croatia and PRO PLUS Slovenia
Published on 09/11/2026 at 22:15, 1 day 20 hours ago

Amrize Appoints Mario Gross as President of Building Envelope
Published on 09/11/2026 at 22:10, 1 day 20 hours ago

Quantinuum to Participate in the Piper Sandler 5th Annual Growth Frontiers Conference
Published on 09/11/2026 at 19:44, 1 day 22 hours ago

DocMorris announces final conversion price and issue size of its New Convertible Bonds due 2031

View all EQS

Published on 09/11/2026 at 07:00, 2 days 11 hours ago

Transparency notification by Baltisse Group
Published on 09/11/2026 at 07:00, 2 days 11 hours ago

BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Published on 09/10/2026 at 19:30, 2 days 23 hours ago

Availability of the 2026 Interim Financial Report
Published on 09/10/2026 at 07:00, 3 days 11 hours ago

2026 H1 results and new identity
Published on 09/09/2026 at 18:45, 3 days 23 hours ago

Successful launch of a €500 million bond issue

View all LES ECHOS COMFI WIRE

News